Tips for Drug Discovery

Solubility is a key factor in the bioavailability of drug candidates, influencing their absorption, distribution, and overall effectiveness. Solubility testing is essential in preclinical studies to evaluate how well a drug dissolves in a specific solvent, which directly impacts its therapeutic potential. This guide outlines how to perform solubility testing for drug candidates:
Click to read the full article.

Formulations are critical in drug development as they ensure the effective delivery of the active pharmaceutical ingredient (API). Preparing screening formulations for testing is an essential step in preclinical research, allowing for the evaluation of drug candidates’ stability, solubility, and bioavailability. This guide outlines the steps involved in preparing screening formulations for testing:
Click to read the full article.

Animal testing is a necessary step in preclinical drug development, but it must be conducted in compliance with international guidelines to ensure the safety and welfare of animals, as well as the scientific integrity of the research. This guide outlines the key global regulations governing animal testing and provides recommendations for ensuring compliance:
Click to read the full article.

Animal studies are a critical part of preclinical research, providing essential data on the safety and efficacy of drug candidates. Preparing and submitting comprehensive animal study reports is an essential part of the process, ensuring that regulatory agencies, stakeholders, and the scientific community have access to accurate and reliable data. This FAQ guide explains the steps involved in preparing and submitting animal study reports:
Click to read the full article.

Data review meetings are an important aspect of preclinical studies, allowing researchers to analyze, interpret, and discuss study findings in a collaborative environment. These meetings help ensure that the data is properly understood, that issues are addressed, and that decisions are made based on reliable information. This guide outlines how to conduct effective preclinical study data review meetings:
Click to read the full article.

Omics-based studies, including genomics, proteomics, and metabolomics, provide comprehensive insights into biological systems by analyzing large-scale molecular data. The success of these studies largely depends on the quality of the samples used. Proper sample preparation ensures that the data obtained is reliable, reproducible, and interpretable. This guide outlines how to prepare samples for omics-based studies:
Click to read the full article.

Effective documentation and record keeping are essential components of preclinical studies, ensuring that all experimental procedures, data, and results are accurately recorded and easily accessible for future review. Proper documentation supports regulatory compliance, enables transparency, and ensures the reproducibility of results. This guide outlines how to implement proper documentation and record-keeping practices in preclinical studies:
Click to read the full article.

Risk management is a critical component of preclinical drug development, aimed at identifying, assessing, and mitigating potential risks that could impact the safety, efficacy, and success of a drug candidate. Implementing an effective risk management strategy ensures that potential challenges are addressed early in the development process, ultimately reducing the risk of failure during later stages. This guide outlines how to implement risk management in preclinical studies:
Click to read the full article.

Statistical analysis is crucial in preclinical studies to ensure that the data collected is valid, reliable, and can support meaningful conclusions. Proper statistical methods allow researchers to determine the significance of their findings and identify trends or patterns that could influence drug development. This FAQ guide explains how to perform statistical analysis of preclinical data:
Click to read the full article.

Monitoring the progress of preclinical studies is crucial for ensuring that the study is conducted according to plan, within budget, and on schedule. Timely oversight allows researchers to identify potential issues early, make necessary adjustments, and ensure the study meets scientific and regulatory standards. This guide outlines how to monitor preclinical study progress effectively:
Click to read the full article.

Collaborating with external preclinical testing labs, also known as Contract Research Organizations (CROs), is common in drug development to leverage specialized expertise, infrastructure, and resources. This collaboration helps streamline the drug development process and reduce costs. This guide outlines how to effectively collaborate with external preclinical testing labs:
Click to read the full article.

Data quality is a critical aspect of preclinical studies, as reliable and reproducible data ensures the accuracy of research findings and supports decision-making in drug development. Ensuring data quality involves implementing best practices in study design, data collection, and analysis. This FAQ guide outlines how to ensure data quality in preclinical studies:
Click to read the full article.